Cullinan Therapeutics, Inc. (CGEM)
11.20
-0.53
(-4.52%)
USD |
NASDAQ |
Nov 10, 16:00
11.20
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Cash from Operations (Annual) : -175.75M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -175.75M |
| December 31, 2024 | -145.30M |
| December 31, 2023 | -134.28M |
| December 31, 2022 | -126.66M |
| Date | Value |
|---|---|
| December 31, 2021 | -43.43M |
| December 31, 2020 | -29.77M |
| December 31, 2019 | -20.90M |
| December 31, 2018 | -13.55M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Climb Bio, Inc. | -54.36M |
| MapLight Therapeutics, Inc. | -138.14M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |